PGEN Company Profile and Key Details
Precigen, Inc.
PGEN Stock Price Chart
Stock Price Today
Precigen, Inc. (PGEN) stock declined over -4.24%, trading at $1.13 on NASDAQ, down from the previous close of $1.18. The stock opened at $1.16, fluctuating between $1.11 and $1.19 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Company Information
| Employees | 202 |
| Beta | 1.68 |
| Sales or Revenue | $6.23M |
| 5Y Sales Change% | -0.979% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Precigen, Inc. (NASDAQ: PGEN) stock price is $1.13 in the last trading session. During the trading session, PGEN stock reached the peak price of $1.19 while $1.11 was the lowest point it dropped to. The percentage change in PGEN stock occurred in the recent session was -4.24% while the dollar amount for the price change in PGEN stock was -$0.05.
The NASDAQ listed PGEN is part of Biotechnology industry that operates in the broader Healthcare sector. Precigen, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Harry Thomasian Jr.
Chief Financial Officer
Dr. Thomas D. Reed
Founder & Chief Science Officer
Mr. Steven Harasym
Vice President & Head of Investor Relations
Mr. Donald P. Lehr
Chief Legal Officer & Corporation Sec.
Dr. Helen Sabzevari MPH, Ph.D.
Pres, Chief Executive Officer & Director
Mr. Jeffrey Thomas Perez
Senior Vice President of Intellectual Property Affairs
Mr. Randal J. Kirk J.D.
Executive Chairman
Marie Rossi
Vice President of Communications
Mr. Rutul R. Shah
Chief Operating Officer
Dr. Thomas D. Reed Ph.D.
Founder & Chief Science Officer
Mr. Rob Russell
Vice President & Head of HR
PGEN's closing price is 81.54% higher than its 52-week low of $0.65 where as its distance from 52-week high of $1.93 is -38.86%.
Number of PGEN employees currently stands at 202.
Official Website of PGEN is: https://www.precigen.com
PGEN could be contacted at phone 301 556 9900 and can also be accessed through its website. PGEN operates from 20374 Seneca Meadows Parkway, Germantown, MD 20876, United States.
PGEN stock volume for the day was 778.17K shares. The average number of PGEN shares traded daily for last 3 months was 1.4M.
The market value of PGEN currently stands at $330.94M with its latest stock price at $1.13 and 292.87M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com